Mechanisms of Platelet Activation in Acute Coronary Syndromes

By  

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 578-588

Bentham Science Publishers

Access to resources Recommend Favorite

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

By Villmow T.   Kemkes-Matthes B.   Matzdorff A.C.  

Thrombosis Research, Vol. 108, Iss. 2, 2002-11 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes

By Mascelli Mary   Deliargyris Efthymios   Damaraju Lakshmi   Barnathan Elliot   Califf Robert   Simoons Maarten   Sane David  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 171-175

Springer Publishing Company

Access to resources Recommend Favorite

Near patient anti-platelet response testing over time and gene analysis in patients admitted with acute coronary syndromes

By Amoah Vincent   Storey Robert F.   Worrall Andrew P.   Goodridge Kevin   Lovatt Tracy   Smallwood Andrew   Armesilla Angel L.   Nevill Alan M.   Cotton James M.  

Platelets, Vol. 24, Iss. 8, 2013-12 ,pp. : 643-648

Informa Healthcare

Access to resources Recommend Favorite

Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting

By Huczek Zenon   Filipiak Krzysztof J.   Kochman Janusz   Michalak Marcin   Roik Marek   Grabowski Marcin   Opolski Grzegorz  

Platelets, Vol. 22, Iss. 7, 2011-11 ,pp. : 521-529

Informa Healthcare

Access to resources Recommend Favorite